Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea

Short Communication
Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea

Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust

Journal of Biological Sciences, 2013, 13(8), 727-731.

Abstract

This study aimed at evaluating the efficacy of oral erythromycin in patients with Pityriasis Rosea. Fifty patients were selected which were the divided into 2 groups. In group A (test group) the patients were treated by erythromycin while in group B (plecebo group) the patients received chlorpheniramin or diphenhydramin. Complete response was observed in 16 patients (64%) in the treatment group (A) and none in the second group (B) (p = 0/0001). It is recommended to treat the patients suffering from pityriasis rosea at any time of disease diagnosis using oral erythromycin for a two-week period.

ASCI-ID: 38-2261

Cited References Fulltext